Brighton Jones’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Buy
4,353
+2,193
+102% +$507K 0.02% 518
2026
Q2
$458K Buy
2,160
+173
+9% +$34K 0.01% 828
2026
Q1
$389K Buy
+1,987
New +$386K 0.01% 806
2025
Q4
– Sell
-2,548
Closed -$486K – 270
2025
Q3
$486K Buy
2,548
+19
+0.8% +$3.37K 0.01% 640
2025
Q2
$454K Buy
2,529
+350
+16% +$60.8K 0.01% 572
2025
Q1
$369K Buy
2,179
+35
+2% +$5.75K 0.01% 474
2024
Q4
$323K Buy
+2,144
New +$333K 0.01% 499
2024
Q3
– Sell
-1,760
Closed -$241K – 602
2024
Q2
$241K Buy
1,760
+62
+4% +$8.49K 0.01% 523
2024
Q1
$226K Buy
1,698
+4
+0.2% +$519 0.01% 540
2023
Q4
$234K Buy
+1,694
New +$223K 0.01% 501
2023
Q3
– Sell
-1,531
Closed -$215K – 553
2023
Q2
$215K Sell
1,531
-42
-3% -$5.79K 0.01% 491
2023
Q1
$223K Buy
1,573
+84
+6% +$12K 0.01% 447
2022
Q4
$233K Buy
+1,489
New +$214K 0.01% 399
2022
Q1
– Sell
-1,351
Closed -$234K – 522
2021
Q4
$234K Buy
+1,351
New +$206K 0.01% 446
2021
Q2
– Sell
-1,843
Closed -$237K – 484
2021
Q1
$237K Buy
1,843
+15
+0.8% +$1.85K 0.01% 362
2020
Q4
$218K Buy
1,828
+2
+0.1% +$244 0.01% 347
2020
Q3
$209K Buy
+1,826
New +$216K 0.01% 309
2020
Q1
– Sell
-1,954
Closed -$209K – 289
2019
Q4
$209K Hold
1,954
– – 0.02% 301
2019
Q3
$209K Sell
1,954
-37
-2% -$3.8K 0.02% 290
2019
Q2
$203K Buy
+1,991
New +$191K 0.02% 289
2017
Q3
– Sell
-2,016
Closed -$224K – 296
2017
Q2
$224K Buy
+2,016
New +$213K 0.03% 244

Other funds holding DGX

Brighton Jones's DGX Position: Q3 2026 in Review

Brighton Jones increased its Quest Diagnostics (DGX) stake by 102% in Q3 2026, buying an estimated $507K and bringing the position to 4,353 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #518.

Brighton Jones first reported a position in DGX in Q2 2017 and has held it in 21 quarters since. 1,139 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Brighton Jones held 4,353 shares of Quest Diagnostics worth $1.01M as of Q3 2026.
  • Brighton Jones bought 2,193 Quest Diagnostics shares in Q3 2026, an estimated $507K.
  • Quest Diagnostics made up 0.02% of Brighton Jones's portfolio in Q3 2026, its #518 holding.
  • Brighton Jones first reported a position in Quest Diagnostics in Q2 2017 and has held it in 21 quarters since.
  • 1,139 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.